• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SC 13G/A filed by RadNet Inc.

    10/24/24 6:36:21 PM ET
    $RDNT
    Medical Specialities
    Health Care
    Get the next $RDNT alert in real time by email
    SC 13G/A 1 radnet_kaminsky-sc13ga2.htm AMENDMENT NO. 2

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    SCHEDULE 13G

     

    INFORMATION TO BE INCLUDED

    IN STATEMENTS FILED PURSUANT

    TO RULES 13d-1(b), (c), AND

    (d) AND AMENDMENTS THERETO

    FILED PURSUANT TO RULE 13d-2

     

    (Amendment No. 2)

     

    RADNET, INC.

    (Name of Issuer)

     

    Common Stock, $0.0001 par value

    (Title of Class of Securities)

     

    750491102

    (CUSIP Number)

     

    September 30, 2024

    (Date of Event Which Requires Filing of this Statement)

     

    oRule 13d-1(b)
    xRule 13d-1(c)
    oRule 13d-1(d)

     

     

    * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

     

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     

     
     

     

    SCHEDULE 13G

     

    CUSIP No. 750491102   Page 2 of 6 Pages

     

    1

    NAME OF REPORTING PERSON

     

    Sandy Nyholm Kaminsky, as trustee of the HFB Heirs’ Trust II (formerly HFB Heirs’ Family Trust)

    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a) o

    (b) o

    3 SEC USE ONLY
    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    United States


     

    NUMBER OF

    5

    SOLE VOTING POWER

     

    4,551,753

    SHARES

    BENEFICIALLY
    OWNED BY

    6

    SHARED VOTING POWER

     

    0

    EACH
    REPORTING
    PERSON
    7

    SOLE DISPOSITIVE POWER

     

    4,551,753

    WITH
    8

    SHARED DISPOSITIVE POWER

     

    0

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    4,551,753

    10

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES o

     

     

    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    6.158%+

    12

    TYPE OF REPORTING PERSON

     

    OO

           

    _______________________

    +Calculated using the number of outstanding shares of common stock as of August 5, 2024 reported in the Issuer's Form 10-Q filed with the U.S. Securities and Exchange Commission August 9, 2024.

     
     

     

    SCHEDULE 13G

     

    CUSIP No. 750491102   Page 3 of 6 Pages

     

    Item 1.Issuer.

     

    (a)          The name of the issuer is RadNet, Inc. (the “Issuer”).

     

    (b)          The address of the Issuer’s principal executive office is 1510 Cotner Avenue, Los Angeles, California 90025

     

    Item 2.Reporting Person and Security.

     

    (a)          Sandy Nyholm Kaminsky, as trustee of the HFB Heirs’ Trust II (formerly the HFB Heirs’ Family Trust) (the “Reporting Person”).

     

    (b)          The Reporting Person’s address is 400 S. Emerson Street, Denver Colorado 80209.

     

    (c)          The Reporting Person is a United States citizen.

     

    (d)          The title of the class of securities to which this statement relates is the common stock, $0.0001 par value, of the Issuer (the “Common Stock”).

     

    (e)          The CUSIP number is 750491102.

     

    Item 3.If This Statement is Filed Pursuant to Rule 13d-1(b) or 13d-2(b) or (c), Check Whether the Person Filing is a:

     

    (a)          [  ] Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o);

     

    (b)          [  ] Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c);

     

    (c)          [  ] Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c);

     

    (d)          [  ] Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);

     

    (e)          [  ] An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);

     

    (f)           [  ] An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);

     

    (g)          [  ] A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);

     

    (h)          [  ] A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

     

     
     

     

    SCHEDULE 13G

     

    CUSIP No. 750491102   Page 4 of 6 Pages

     

    (i)          [  ] A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);

     

    (j)          [  ] A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J);

     

    (k)         [  ] Group, in accordance with § 240.13d-1(b)(1)(ii)(J).

     

    Not applicable.

     

    Item 4.Ownership.

     

    (a)Amount beneficially owned: 4,551,753 shares of Common Stock held by HFB Heirs’ Trust II of which the Reporting Person is the trustee.
    (b)Percent of Class: 6.15% (based on 73,957,260 outstanding shares of Common Stock as of August 5, 2024 reported in the Issuer's Form 10-Q filed August 9, 2024).
    (c)Number of shares as to which the Reporting Person has:

    (i)          Sole power to vote or to direct the vote: 4,551,753

     

    (ii)         Shared power to vote or to direct the vote: 0;

     

    (iii)        Sole power to dispose or to direct the disposition of: 4,551,753; and

     

    (iv)        Shared power to dispose or to direct the disposition of: 0.

     

    Item 5.Ownership of Five Percent or Less of a Class.

    If this Schedule is being filed to report the fact that as of the date hereof the Reporting Person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [  ]

     

    Not applicable.

     

    Item 6.Ownership of More than Five Percent on Behalf of Another Person.

    Not applicable.

     

    Item 7.Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person.

     

    Not applicable.

     

    Item 8.Identification and Classification of Members of the Group.

    Not applicable.

     

     
     

     

    SCHEDULE 13G

     

    CUSIP No. 750491102   Page 5 of 6 Pages

     

    Item 9.Notice of Dissolution of Group.

     

    Not applicable.

     

    Item 10.Certifications.

    (a)         Not applicable.

     

    (b)         Not applicable.

     

    (c)         By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

     

     

     

     

     

     

     

     

     

     

     

     

     
     

     

    SCHEDULE 13G

     

    CUSIP No. 750491102   Page 6 of 6 Pages

     

    SIGNATURE

     

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

    Dated: October 24, 2024

    /s/ Sandy Nyhom Kaminsky
    ** Signature of Reporting Person**

       
       
      /s/ Sandy Nyholm Kaminsky, as trustee of the HFB Heirs’ Trust II
      (formerly HFB Heirs’ Family Trust)
      **Signature of Reporting Person**

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Get the next $RDNT alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $RDNT

    DatePrice TargetRatingAnalyst
    3/5/2025$85.00 → $65.00Outperform → Strong Buy
    Raymond James
    9/6/2024$57.00 → $79.00Equal Weight → Overweight
    Barclays
    3/6/2024$48.00Equal Weight
    Barclays
    8/31/2023$40.00Buy
    Truist
    3/31/2023$30.00Market Outperform
    CJS Securities
    3/3/2023$30.00Mkt Perform → Outperform
    Raymond James
    8/12/2021Outperform → Market Perform
    Raymond James
    8/12/2021$39.00Overweight
    Barclays
    More analyst ratings

    $RDNT
    Financials

    Live finance-specific insights

    See more
    • RadNet, Inc. Acquires See-Mode Technologies for Innovation in AI-Powered Ultrasound Diagnostics

      See-Mode's commercially available AI-powered ultrasound detection, characterization, and reporting solutions for thyroid and breast will be integrated into RadNet's DeepHealth population health solutionsReal-world deployment of See-Mode's FDA-approved thyroid ultrasound solution at RadNet imaging centers demonstrates improved workflow efficiency and enhanced diagnostic accuracy The acquisition positions RadNet at the forefront of AI innovation in ultrasound LOS ANGELES, June 04, 2025 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ:RDNT) ("RadNet"), a national leader in providing high-quality, cost-effective diagnostic imaging services and digital health solutions through its wholly-owned subsidi

      6/4/25 4:01:00 PM ET
      $RDNT
      Medical Specialities
      Health Care
    • RadNet Reports First Quarter Financial Results and Revises Upwards 2025 Financial Guidance Ranges for Revenue and Adjusted EBITDA¹

      First quarter Revenue was negatively impacted by approximately $22 million and Adjusted EBITDA(1) was negatively impacted by approximately $15 million as a result of the Southern California wildfires and severe winter weather conditionsTotal Company Revenue increased 9.2% to $471.4 million in the first quarter of 2025 from $431.7 million in the first quarter of 2024Revenue from the Digital Health reportable segment increased 31.1% to $19.2 million in the first quarter of 2025 from $14.7 million in the first quarter of 2024Aggregate procedural volumes increased 3.6% and same-center procedural volumes decreased 0.3% compared with the first quarter of 2024Total Company Adjusted EBITDA(1) was $4

      5/11/25 4:00:00 PM ET
      $RDNT
      Medical Specialities
      Health Care
    • RadNet, Inc. Announces Date of its First Quarter 2025 Financial Results Conference Call

      LOS ANGELES, April 24, 2025 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ:RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and operated outpatient imaging centers, announced today that it will host a conference call to discuss its first quarter 2025 financial results on Monday, May 12, 2025 at 7:30 a.m. Pacific Time (10:30 a.m. Eastern Time). Investors are invited to listen to RadNet's conference call by dialing 844-826-3035. International callers can dial 412-317-5195. There will also be simultaneous and archived webcasts available at https://viavid.webcasts.com/starthere.jsp?ei=1717619&tp_key=f0980d090d. An archived r

      4/24/25 6:00:00 AM ET
      $RDNT
      Medical Specialities
      Health Care

    $RDNT
    Leadership Updates

    Live Leadership Updates

    See more
    • RadNet, Inc. Announces the Appointment of Kees Wesdorp as President and Chief Executive Officer of RadNet's Digital Health Division

      Former Chief Business Leader of Philips' multi-billion-dollar Precision Diagnosis division and member of Philips' Executive CommitteeEnd-to-end responsibility for Philip's CT, MR, dXR, Ultrasound and Diagnostic Informatics (radiology software) businessesProven track record of building and managing radiology software solutions, including significant experience with AI development and commercialization LOS ANGELES, Sept. 12, 2024 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ:RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers and digital health solutions, announced today the appo

      9/12/24 6:00:00 AM ET
      $RDNT
      Medical Specialities
      Health Care

    $RDNT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • RadNet upgraded by Raymond James with a new price target

      Raymond James upgraded RadNet from Outperform to Strong Buy and set a new price target of $65.00 from $85.00 previously

      3/5/25 7:50:00 AM ET
      $RDNT
      Medical Specialities
      Health Care
    • RadNet upgraded by Barclays with a new price target

      Barclays upgraded RadNet from Equal Weight to Overweight and set a new price target of $79.00 from $57.00 previously

      9/6/24 7:50:42 AM ET
      $RDNT
      Medical Specialities
      Health Care
    • Barclays initiated coverage on RadNet with a new price target

      Barclays initiated coverage of RadNet with a rating of Equal Weight and set a new price target of $48.00

      3/6/24 8:01:30 AM ET
      $RDNT
      Medical Specialities
      Health Care

    $RDNT
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • RadNet, Inc. Acquires See-Mode Technologies for Innovation in AI-Powered Ultrasound Diagnostics

      See-Mode's commercially available AI-powered ultrasound detection, characterization, and reporting solutions for thyroid and breast will be integrated into RadNet's DeepHealth population health solutionsReal-world deployment of See-Mode's FDA-approved thyroid ultrasound solution at RadNet imaging centers demonstrates improved workflow efficiency and enhanced diagnostic accuracy The acquisition positions RadNet at the forefront of AI innovation in ultrasound LOS ANGELES, June 04, 2025 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ:RDNT) ("RadNet"), a national leader in providing high-quality, cost-effective diagnostic imaging services and digital health solutions through its wholly-owned subsidi

      6/4/25 4:01:00 PM ET
      $RDNT
      Medical Specialities
      Health Care
    • RadNet Reports First Quarter Financial Results and Revises Upwards 2025 Financial Guidance Ranges for Revenue and Adjusted EBITDA¹

      First quarter Revenue was negatively impacted by approximately $22 million and Adjusted EBITDA(1) was negatively impacted by approximately $15 million as a result of the Southern California wildfires and severe winter weather conditionsTotal Company Revenue increased 9.2% to $471.4 million in the first quarter of 2025 from $431.7 million in the first quarter of 2024Revenue from the Digital Health reportable segment increased 31.1% to $19.2 million in the first quarter of 2025 from $14.7 million in the first quarter of 2024Aggregate procedural volumes increased 3.6% and same-center procedural volumes decreased 0.3% compared with the first quarter of 2024Total Company Adjusted EBITDA(1) was $4

      5/11/25 4:00:00 PM ET
      $RDNT
      Medical Specialities
      Health Care
    • RadNet, Inc. to Present at the Bank of America Securities 2025 Healthcare Conference on May 13th, 2025

      LOS ANGELES, May 09, 2025 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ:RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers, today announced that Mark Stolper, Executive Vice President and Chief Financial Officer will be presenting at the Bank of America Securities 2025 Healthcare Conference in Las Vegas, NV on Tuesday, May 13, 2025 at 5:00 p.m. Pacific Time. There will be simultaneous and archived webcasts available at https://bofa.veracast.com/webcasts/bofa/healthcare2025/id0NMyx8.cfm Details for RadNet's Presentation: Date:Tuesday, May 13, 2025Time:5:00 p.m. Pacific TimeLocat

      5/9/25 6:00:00 AM ET
      $RDNT
      Medical Specialities
      Health Care

    $RDNT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by RadNet Inc.

      SC 13G/A - RadNet, Inc. (0000790526) (Subject)

      11/12/24 4:51:53 PM ET
      $RDNT
      Medical Specialities
      Health Care
    • Amendment: SEC Form SC 13G/A filed by RadNet Inc.

      SC 13G/A - RadNet, Inc. (0000790526) (Subject)

      11/4/24 1:22:38 PM ET
      $RDNT
      Medical Specialities
      Health Care
    • Amendment: SEC Form SC 13G/A filed by RadNet Inc.

      SC 13G/A - RadNet, Inc. (0000790526) (Subject)

      10/24/24 6:36:21 PM ET
      $RDNT
      Medical Specialities
      Health Care

    $RDNT
    SEC Filings

    See more
    • SEC Form EFFECT filed by RadNet Inc.

      EFFECT - RadNet, Inc. (0000790526) (Filer)

      5/22/25 12:15:18 AM ET
      $RDNT
      Medical Specialities
      Health Care
    • SEC Form 424B3 filed by RadNet Inc.

      424B3 - RadNet, Inc. (0000790526) (Filer)

      5/21/25 5:10:55 PM ET
      $RDNT
      Medical Specialities
      Health Care
    • Amendment: SEC Form S-4/A filed by RadNet Inc.

      S-4/A - RadNet, Inc. (0000790526) (Filer)

      5/19/25 5:23:08 PM ET
      $RDNT
      Medical Specialities
      Health Care

    $RDNT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • EVP, Mergers and Acquisitions Murdock Michael N sold $646,213 worth of shares (11,132 units at $58.05), decreasing direct ownership by 21% to 43,084 units (SEC Form 4)

      4 - RadNet, Inc. (0000790526) (Issuer)

      6/6/25 4:15:25 PM ET
      $RDNT
      Medical Specialities
      Health Care
    • EVP, Chief Science Officer Sorensen Alma Gregory was granted 10,436 shares, increasing direct ownership by 0.90% to 1,170,945 units (SEC Form 4)

      4 - RadNet, Inc. (0000790526) (Issuer)

      6/3/25 4:15:17 PM ET
      $RDNT
      Medical Specialities
      Health Care
    • EVP, Chief Science Officer Sorensen Alma Gregory sold $5,674,100 worth of shares (100,000 units at $56.74), decreasing direct ownership by 8% to 1,160,509 units (SEC Form 4)

      4 - RadNet, Inc. (0000790526) (Issuer)

      5/27/25 4:15:08 PM ET
      $RDNT
      Medical Specialities
      Health Care